nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—urinary bladder cancer	0.252	0.515	CiPCiCtD
Azathioprine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—urinary bladder cancer	0.237	0.485	CiPCiCtD
Azathioprine—GSTM1—urinary bladder cancer	0.189	1	CbGaD
Azathioprine—GSTM1—Carboplatin—urinary bladder cancer	0.0709	0.349	CbGbCtD
Azathioprine—GSTM1—Cisplatin—urinary bladder cancer	0.0606	0.298	CbGbCtD
Azathioprine—XDH—Carboplatin—urinary bladder cancer	0.0295	0.145	CbGbCtD
Azathioprine—XDH—Cisplatin—urinary bladder cancer	0.0252	0.124	CbGbCtD
Azathioprine—XDH—Doxorubicin—urinary bladder cancer	0.0169	0.0831	CbGbCtD
Azathioprine—GSTA1—urine—urinary bladder cancer	0.00353	0.124	CbGeAlD
Azathioprine—GSTM1—urine—urinary bladder cancer	0.00261	0.0919	CbGeAlD
Azathioprine—GSTA2—urine—urinary bladder cancer	0.00255	0.0896	CbGeAlD
Azathioprine—GSTA1—prostate gland—urinary bladder cancer	0.00127	0.0446	CbGeAlD
Azathioprine—HPRT1—prostate gland—urinary bladder cancer	0.000961	0.0338	CbGeAlD
Azathioprine—XDH—prostate gland—urinary bladder cancer	0.000949	0.0334	CbGeAlD
Azathioprine—GSTM1—prostate gland—urinary bladder cancer	0.000938	0.033	CbGeAlD
Azathioprine—GSTA1—epithelium—urinary bladder cancer	0.000932	0.0328	CbGeAlD
Azathioprine—GSTA2—prostate gland—urinary bladder cancer	0.000915	0.0322	CbGeAlD
Azathioprine—GSTA1—renal system—urinary bladder cancer	0.000864	0.0304	CbGeAlD
Azathioprine—HPRT1—seminal vesicle—urinary bladder cancer	0.000813	0.0286	CbGeAlD
Azathioprine—TPMT—prostate gland—urinary bladder cancer	0.00081	0.0285	CbGeAlD
Azathioprine—GSTA1—female reproductive system—urinary bladder cancer	0.000692	0.0243	CbGeAlD
Azathioprine—TPMT—seminal vesicle—urinary bladder cancer	0.000685	0.0241	CbGeAlD
Azathioprine—HPRT1—smooth muscle tissue—urinary bladder cancer	0.00068	0.0239	CbGeAlD
Azathioprine—GSTA2—epithelium—urinary bladder cancer	0.000672	0.0236	CbGeAlD
Azathioprine—HPRT1—renal system—urinary bladder cancer	0.000655	0.023	CbGeAlD
Azathioprine—XDH—renal system—urinary bladder cancer	0.000647	0.0227	CbGeAlD
Azathioprine—HPRT1—urethra—urinary bladder cancer	0.000643	0.0226	CbGeAlD
Azathioprine—GSTM1—renal system—urinary bladder cancer	0.000639	0.0225	CbGeAlD
Azathioprine—GSTA2—renal system—urinary bladder cancer	0.000624	0.0219	CbGeAlD
Azathioprine—TPMT—renal system—urinary bladder cancer	0.000552	0.0194	CbGeAlD
Azathioprine—TPMT—urethra—urinary bladder cancer	0.000542	0.0191	CbGeAlD
Azathioprine—HPRT1—female reproductive system—urinary bladder cancer	0.000524	0.0184	CbGeAlD
Azathioprine—XDH—female reproductive system—urinary bladder cancer	0.000518	0.0182	CbGeAlD
Azathioprine—GSTM1—female reproductive system—urinary bladder cancer	0.000512	0.018	CbGeAlD
Azathioprine—GSTA2—female reproductive system—urinary bladder cancer	0.000499	0.0176	CbGeAlD
Azathioprine—HPRT1—vagina—urinary bladder cancer	0.000474	0.0167	CbGeAlD
Azathioprine—XDH—vagina—urinary bladder cancer	0.000469	0.0165	CbGeAlD
Azathioprine—TPMT—vagina—urinary bladder cancer	0.0004	0.0141	CbGeAlD
Azathioprine—HPRT1—lymph node—urinary bladder cancer	0.000307	0.0108	CbGeAlD
Azathioprine—GSTM1—lymph node—urinary bladder cancer	0.000299	0.0105	CbGeAlD
Azathioprine—TPMT—lymph node—urinary bladder cancer	0.000259	0.0091	CbGeAlD
Azathioprine—GSTM1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000231	0.00455	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000231	0.00454	CbGpPWpGaD
Azathioprine—GSTM1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000231	0.00454	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—GSTO2—urinary bladder cancer	0.000228	0.00448	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—NAT1—urinary bladder cancer	0.000228	0.00448	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—CYP4B1—urinary bladder cancer	0.000224	0.0044	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—GSTO2—urinary bladder cancer	0.000222	0.00436	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—NAT1—urinary bladder cancer	0.000222	0.00436	CbGpPWpGaD
Azathioprine—TPMT—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000221	0.00434	CbGpPWpGaD
Azathioprine—GSTM1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000219	0.0043	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—NAT2—urinary bladder cancer	0.000214	0.0042	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000209	0.0041	CbGpPWpGaD
Azathioprine—GSTM1—Phase II conjugation—NAT2—urinary bladder cancer	0.000208	0.00408	CbGpPWpGaD
Azathioprine—TPMT—Phase II conjugation—HPGDS—urinary bladder cancer	0.000204	0.004	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000203	0.00399	CbGpPWpGaD
Azathioprine—GSTM1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.0002	0.00393	CbGpPWpGaD
Azathioprine—HPRT1—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000199	0.00391	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000199	0.00391	CbGpPWpGaD
Azathioprine—TPMT—Phase II conjugation—GSTT1—urinary bladder cancer	0.000198	0.00388	CbGpPWpGaD
Azathioprine—HPRT1—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000188	0.0037	CbGpPWpGaD
Azathioprine—XDH—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000188	0.0037	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000188	0.00369	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—NAT2—urinary bladder cancer	0.000185	0.00364	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000183	0.00359	CbGpPWpGaD
Azathioprine—XDH—Oxidative Stress—SOD2—urinary bladder cancer	0.000181	0.00356	CbGpPWpGaD
Azathioprine—GSTM1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00018	0.00354	CbGpPWpGaD
Azathioprine—XDH—Oxidative Stress—GPX1—urinary bladder cancer	0.000173	0.00339	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000171	0.00336	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—MPO—urinary bladder cancer	0.00017	0.00335	CbGpPWpGaD
Azathioprine—GSTA1—Phase II conjugation—GSTP1—urinary bladder cancer	0.00017	0.00334	CbGpPWpGaD
Azathioprine—GSTM1—Phase II conjugation—HPGDS—urinary bladder cancer	0.000166	0.00326	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000166	0.00325	CbGpPWpGaD
Azathioprine—GSTM1—Phase II conjugation—GSTT1—urinary bladder cancer	0.000161	0.00317	CbGpPWpGaD
Azathioprine—XDH—Purine metabolism—GPX1—urinary bladder cancer	0.00016	0.00315	CbGpPWpGaD
Azathioprine—GSTA1—Phase II conjugation—GSTM1—urinary bladder cancer	0.000156	0.00307	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—NAT2—urinary bladder cancer	0.000149	0.00293	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—HPGDS—urinary bladder cancer	0.000148	0.00291	CbGpPWpGaD
Azathioprine—TPMT—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000147	0.00289	CbGpPWpGaD
Azathioprine—XDH—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000147	0.00288	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—GSTT1—urinary bladder cancer	0.000143	0.00282	CbGpPWpGaD
Azathioprine—TPMT—Phase II conjugation—GSTP1—urinary bladder cancer	0.000137	0.00269	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—NQO1—urinary bladder cancer	0.000136	0.00267	CbGpPWpGaD
Azathioprine—TPMT—Phase II conjugation—GSTM1—urinary bladder cancer	0.000126	0.00247	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—NAT2—urinary bladder cancer	0.000125	0.00246	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000122	0.0024	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—NAT2—urinary bladder cancer	0.000122	0.00239	CbGpPWpGaD
Azathioprine—GSTM1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00012	0.00236	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—HPGDS—urinary bladder cancer	0.000119	0.00234	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—GSTT1—urinary bladder cancer	0.000116	0.00227	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000115	0.00226	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—GSTP1—urinary bladder cancer	0.000113	0.00223	CbGpPWpGaD
Azathioprine—GSTM1—Phase II conjugation—GSTP1—urinary bladder cancer	0.000112	0.00219	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000106	0.00209	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000105	0.00207	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—GSTM1—urinary bladder cancer	0.000104	0.00205	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—HPGDS—urinary bladder cancer	9.99e-05	0.00196	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—GSTP1—urinary bladder cancer	9.94e-05	0.00195	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—HPGDS—urinary bladder cancer	9.71e-05	0.00191	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—GSTT1—urinary bladder cancer	9.69e-05	0.0019	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—GSTT1—urinary bladder cancer	9.42e-05	0.00185	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	9.26e-05	0.00182	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—NQO1—urinary bladder cancer	9.18e-05	0.0018	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—GSTM1—urinary bladder cancer	9.13e-05	0.0018	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—NQO1—urinary bladder cancer	8.93e-05	0.00175	CbGpPWpGaD
Azathioprine—XDH—Nucleotide metabolism—TYMS—urinary bladder cancer	8.49e-05	0.00167	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.31e-05	0.00163	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	8.08e-05	0.00159	CbGpPWpGaD
Azathioprine—XDH—Nucleotide metabolism—GPX1—urinary bladder cancer	8.04e-05	0.00158	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—GSTP1—urinary bladder cancer	8.01e-05	0.00157	CbGpPWpGaD
Azathioprine—TPMT—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.9e-05	0.00155	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—GSTP1—urinary bladder cancer	7.65e-05	0.0015	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—SOD2—urinary bladder cancer	7.65e-05	0.0015	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—GSTP1—urinary bladder cancer	7.45e-05	0.00146	CbGpPWpGaD
Azathioprine—Alopecia—Fluorouracil—urinary bladder cancer	7.42e-05	0.00185	CcSEcCtD
Azathioprine—TPMT—Biological oxidations—GSTM1—urinary bladder cancer	7.36e-05	0.00145	CbGpPWpGaD
Azathioprine—Neoplasm—Epirubicin—urinary bladder cancer	7.36e-05	0.00183	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	7.33e-05	0.00144	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—GPX1—urinary bladder cancer	7.3e-05	0.00144	CbGpPWpGaD
Azathioprine—TPMT—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.26e-05	0.00143	CbGpPWpGaD
Azathioprine—Colitis—Doxorubicin—urinary bladder cancer	7.23e-05	0.0018	CcSEcCtD
Azathioprine—Immune system disorder—Cisplatin—urinary bladder cancer	7.19e-05	0.00179	CcSEcCtD
Azathioprine—Mediastinal disorder—Cisplatin—urinary bladder cancer	7.17e-05	0.00179	CcSEcCtD
Azathioprine—Infection—Thiotepa—urinary bladder cancer	7.16e-05	0.00178	CcSEcCtD
Azathioprine—Arrhythmia—Cisplatin—urinary bladder cancer	7.11e-05	0.00177	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	7.08e-05	0.00139	CbGpPWpGaD
Azathioprine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	7.07e-05	0.00176	CcSEcCtD
Azathioprine—Thrombocytopenia—Thiotepa—urinary bladder cancer	7.06e-05	0.00176	CcSEcCtD
Azathioprine—GSTA2—NRF2 pathway—GSTM1—urinary bladder cancer	7.03e-05	0.00138	CbGpPWpGaD
Azathioprine—Alopecia—Cisplatin—urinary bladder cancer	7.03e-05	0.00175	CcSEcCtD
Azathioprine—Hepatic failure—Methotrexate—urinary bladder cancer	7.02e-05	0.00175	CcSEcCtD
Azathioprine—Skin disorder—Thiotepa—urinary bladder cancer	7e-05	0.00174	CcSEcCtD
Azathioprine—HPRT1—Metabolism—GSTZ1—urinary bladder cancer	6.97e-05	0.00137	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Gemcitabine—urinary bladder cancer	6.9e-05	0.00172	CcSEcCtD
Azathioprine—Erythema multiforme—Etoposide—urinary bladder cancer	6.89e-05	0.00172	CcSEcCtD
Azathioprine—Anaemia—Gemcitabine—urinary bladder cancer	6.87e-05	0.00171	CcSEcCtD
Azathioprine—Neoplasm—Doxorubicin—urinary bladder cancer	6.81e-05	0.0017	CcSEcCtD
Azathioprine—Hepatic function abnormal—Epirubicin—urinary bladder cancer	6.76e-05	0.00168	CcSEcCtD
Azathioprine—Anaemia—Fluorouracil—urinary bladder cancer	6.75e-05	0.00168	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	6.74e-05	0.00133	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	6.74e-05	0.00132	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—GSTP1—urinary bladder cancer	6.71e-05	0.00132	CbGpPWpGaD
Azathioprine—Malaise—Gemcitabine—urinary bladder cancer	6.7e-05	0.00167	CcSEcCtD
Azathioprine—Leukopenia—Gemcitabine—urinary bladder cancer	6.65e-05	0.00166	CcSEcCtD
Azathioprine—HPRT1—Metabolism—GSTO2—urinary bladder cancer	6.6e-05	0.0013	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—NAT1—urinary bladder cancer	6.6e-05	0.0013	CbGpPWpGaD
Azathioprine—Immune system disorder—Etoposide—urinary bladder cancer	6.58e-05	0.00164	CcSEcCtD
Azathioprine—Hepatic failure—Epirubicin—urinary bladder cancer	6.57e-05	0.00164	CcSEcCtD
Azathioprine—Mediastinal disorder—Etoposide—urinary bladder cancer	6.57e-05	0.00164	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	6.57e-05	0.00164	CcSEcCtD
Azathioprine—Chills—Etoposide—urinary bladder cancer	6.54e-05	0.00163	CcSEcCtD
Azathioprine—Leukopenia—Fluorouracil—urinary bladder cancer	6.54e-05	0.00163	CcSEcCtD
Azathioprine—GSTM1—Biological oxidations—GSTP1—urinary bladder cancer	6.53e-05	0.00128	CbGpPWpGaD
Azathioprine—Alopecia—Etoposide—urinary bladder cancer	6.44e-05	0.0016	CcSEcCtD
Azathioprine—GSTM1—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.44e-05	0.00127	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Cisplatin—urinary bladder cancer	6.43e-05	0.0016	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	6.42e-05	0.00126	CbGpPWpGaD
Azathioprine—Anaemia—Cisplatin—urinary bladder cancer	6.4e-05	0.00159	CcSEcCtD
Azathioprine—Arthralgia—Gemcitabine—urinary bladder cancer	6.33e-05	0.00158	CcSEcCtD
Azathioprine—Myalgia—Gemcitabine—urinary bladder cancer	6.33e-05	0.00158	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	6.28e-05	0.00156	CcSEcCtD
Azathioprine—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	6.25e-05	0.00156	CcSEcCtD
Azathioprine—Discomfort—Gemcitabine—urinary bladder cancer	6.25e-05	0.00156	CcSEcCtD
Azathioprine—Malaise—Cisplatin—urinary bladder cancer	6.25e-05	0.00156	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	6.22e-05	0.00155	CcSEcCtD
Azathioprine—Myalgia—Fluorouracil—urinary bladder cancer	6.22e-05	0.00155	CcSEcCtD
Azathioprine—Leukopenia—Cisplatin—urinary bladder cancer	6.2e-05	0.00154	CcSEcCtD
Azathioprine—GSTA2—Biological oxidations—GSTM1—urinary bladder cancer	6.17e-05	0.00121	CbGpPWpGaD
Azathioprine—Discomfort—Fluorouracil—urinary bladder cancer	6.15e-05	0.00153	CcSEcCtD
Azathioprine—GSTA1—Metabolism—GSTZ1—urinary bladder cancer	6.09e-05	0.0012	CbGpPWpGaD
Azathioprine—Hepatic failure—Doxorubicin—urinary bladder cancer	6.08e-05	0.00151	CcSEcCtD
Azathioprine—HPRT1—Metabolism—UGT2B7—urinary bladder cancer	6.04e-05	0.00119	CbGpPWpGaD
Azathioprine—Infection—Gemcitabine—urinary bladder cancer	6.03e-05	0.0015	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	6e-05	0.00118	CbGpPWpGaD
Azathioprine—Feeling abnormal—Thiotepa—urinary bladder cancer	5.94e-05	0.00148	CcSEcCtD
Azathioprine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	5.94e-05	0.00148	CcSEcCtD
Azathioprine—Infection—Fluorouracil—urinary bladder cancer	5.92e-05	0.00148	CcSEcCtD
Azathioprine—Myalgia—Cisplatin—urinary bladder cancer	5.9e-05	0.00147	CcSEcCtD
Azathioprine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	5.9e-05	0.00147	CcSEcCtD
Azathioprine—Skin disorder—Gemcitabine—urinary bladder cancer	5.89e-05	0.00147	CcSEcCtD
Azathioprine—Ill-defined disorder—Etoposide—urinary bladder cancer	5.89e-05	0.00147	CcSEcCtD
Azathioprine—Anaemia—Etoposide—urinary bladder cancer	5.87e-05	0.00146	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	5.86e-05	0.00146	CcSEcCtD
Azathioprine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	5.84e-05	0.00145	CcSEcCtD
Azathioprine—Discomfort—Cisplatin—urinary bladder cancer	5.83e-05	0.00145	CcSEcCtD
Azathioprine—GSTA1—Metabolism—GSTO2—urinary bladder cancer	5.77e-05	0.00113	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—NAT1—urinary bladder cancer	5.77e-05	0.00113	CbGpPWpGaD
Azathioprine—Malaise—Etoposide—urinary bladder cancer	5.72e-05	0.00143	CcSEcCtD
Azathioprine—Body temperature increased—Thiotepa—urinary bladder cancer	5.7e-05	0.00142	CcSEcCtD
Azathioprine—Abdominal pain—Thiotepa—urinary bladder cancer	5.7e-05	0.00142	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	5.68e-05	0.00142	CcSEcCtD
Azathioprine—Leukopenia—Etoposide—urinary bladder cancer	5.68e-05	0.00141	CcSEcCtD
Azathioprine—Hypotension—Gemcitabine—urinary bladder cancer	5.67e-05	0.00141	CcSEcCtD
Azathioprine—Infection—Cisplatin—urinary bladder cancer	5.62e-05	0.0014	CcSEcCtD
Azathioprine—Hypotension—Fluorouracil—urinary bladder cancer	5.57e-05	0.00139	CcSEcCtD
Azathioprine—Thrombocytopenia—Cisplatin—urinary bladder cancer	5.54e-05	0.00138	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	5.53e-05	0.00138	CcSEcCtD
Azathioprine—Skin disorder—Cisplatin—urinary bladder cancer	5.49e-05	0.00137	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CYP4B1—urinary bladder cancer	5.44e-05	0.00107	CbGpPWpGaD
Azathioprine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	5.43e-05	0.00135	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CCND1—urinary bladder cancer	5.42e-05	0.00107	CbGpPWpGaD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	5.37e-05	0.00134	CcSEcCtD
Azathioprine—Pancreatitis—Methotrexate—urinary bladder cancer	5.35e-05	0.00133	CcSEcCtD
Azathioprine—Discomfort—Etoposide—urinary bladder cancer	5.34e-05	0.00133	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	5.32e-05	0.00132	CcSEcCtD
Azathioprine—Hypersensitivity—Thiotepa—urinary bladder cancer	5.31e-05	0.00132	CcSEcCtD
Azathioprine—Hypotension—Cisplatin—urinary bladder cancer	5.28e-05	0.00132	CcSEcCtD
Azathioprine—GSTA1—Metabolism—UGT2B7—urinary bladder cancer	5.28e-05	0.00104	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	5.25e-05	0.00103	CbGpPWpGaD
Azathioprine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	5.24e-05	0.0013	CcSEcCtD
Azathioprine—Abdominal discomfort—Methotrexate—urinary bladder cancer	5.23e-05	0.0013	CcSEcCtD
Azathioprine—Pancytopenia—Methotrexate—urinary bladder cancer	5.18e-05	0.00129	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	5.15e-05	0.00128	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	5.15e-05	0.00128	CcSEcCtD
Azathioprine—Infection—Etoposide—urinary bladder cancer	5.15e-05	0.00128	CcSEcCtD
Azathioprine—HPRT1—Metabolism—SLC19A1—urinary bladder cancer	5.14e-05	0.00101	CbGpPWpGaD
Azathioprine—Thrombocytopenia—Etoposide—urinary bladder cancer	5.07e-05	0.00126	CcSEcCtD
Azathioprine—Skin disorder—Etoposide—urinary bladder cancer	5.03e-05	0.00125	CcSEcCtD
Azathioprine—Pancreatitis—Epirubicin—urinary bladder cancer	5.01e-05	0.00125	CcSEcCtD
Azathioprine—HPRT1—Metabolism—PRSS3—urinary bladder cancer	5e-05	0.000984	CbGpPWpGaD
Azathioprine—Feeling abnormal—Gemcitabine—urinary bladder cancer	5e-05	0.00124	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—EP300—urinary bladder cancer	4.99e-05	0.000981	CbGpPWpGaD
Azathioprine—Diarrhoea—Thiotepa—urinary bladder cancer	4.93e-05	0.00123	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	4.92e-05	0.00123	CcSEcCtD
Azathioprine—Feeling abnormal—Fluorouracil—urinary bladder cancer	4.91e-05	0.00122	CcSEcCtD
Azathioprine—TPMT—Metabolism—GSTZ1—urinary bladder cancer	4.91e-05	0.000965	CbGpPWpGaD
Azathioprine—Pneumonia—Methotrexate—urinary bladder cancer	4.89e-05	0.00122	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	4.88e-05	0.00122	CcSEcCtD
Azathioprine—Infestation—Methotrexate—urinary bladder cancer	4.86e-05	0.00121	CcSEcCtD
Azathioprine—Infestation NOS—Methotrexate—urinary bladder cancer	4.86e-05	0.00121	CcSEcCtD
Azathioprine—Pancytopenia—Epirubicin—urinary bladder cancer	4.85e-05	0.00121	CcSEcCtD
Azathioprine—Hypotension—Etoposide—urinary bladder cancer	4.84e-05	0.00121	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	4.82e-05	0.0012	CcSEcCtD
Azathioprine—Body temperature increased—Gemcitabine—urinary bladder cancer	4.79e-05	0.00119	CcSEcCtD
Azathioprine—Dizziness—Thiotepa—urinary bladder cancer	4.77e-05	0.00119	CcSEcCtD
Azathioprine—GSTA1—Metabolism—CYP4B1—urinary bladder cancer	4.75e-05	0.000934	CbGpPWpGaD
Azathioprine—Body temperature increased—Fluorouracil—urinary bladder cancer	4.71e-05	0.00117	CcSEcCtD
Azathioprine—Feeling abnormal—Cisplatin—urinary bladder cancer	4.66e-05	0.00116	CcSEcCtD
Azathioprine—TPMT—Metabolism—NAT1—urinary bladder cancer	4.65e-05	0.000915	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—GSTO2—urinary bladder cancer	4.65e-05	0.000915	CbGpPWpGaD
Azathioprine—Pancreatitis—Doxorubicin—urinary bladder cancer	4.63e-05	0.00115	CcSEcCtD
Azathioprine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	4.6e-05	0.00115	CcSEcCtD
Azathioprine—Vomiting—Thiotepa—urinary bladder cancer	4.58e-05	0.00114	CcSEcCtD
Azathioprine—Pneumonia—Epirubicin—urinary bladder cancer	4.58e-05	0.00114	CcSEcCtD
Azathioprine—Infestation NOS—Epirubicin—urinary bladder cancer	4.55e-05	0.00113	CcSEcCtD
Azathioprine—Infestation—Epirubicin—urinary bladder cancer	4.55e-05	0.00113	CcSEcCtD
Azathioprine—Rash—Thiotepa—urinary bladder cancer	4.55e-05	0.00113	CcSEcCtD
Azathioprine—Dermatitis—Thiotepa—urinary bladder cancer	4.54e-05	0.00113	CcSEcCtD
Azathioprine—Agranulocytosis—Methotrexate—urinary bladder cancer	4.54e-05	0.00113	CcSEcCtD
Azathioprine—Headache—Thiotepa—urinary bladder cancer	4.52e-05	0.00112	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	4.51e-05	0.00112	CcSEcCtD
Azathioprine—GSTA1—Metabolism—SLC19A1—urinary bladder cancer	4.49e-05	0.000882	CbGpPWpGaD
Azathioprine—Pancytopenia—Doxorubicin—urinary bladder cancer	4.49e-05	0.00112	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	4.47e-05	0.00111	CcSEcCtD
Azathioprine—Body temperature increased—Cisplatin—urinary bladder cancer	4.47e-05	0.00111	CcSEcCtD
Azathioprine—Hypersensitivity—Fluorouracil—urinary bladder cancer	4.39e-05	0.00109	CcSEcCtD
Azathioprine—Haemoglobin—Methotrexate—urinary bladder cancer	4.39e-05	0.00109	CcSEcCtD
Azathioprine—GSTA1—Metabolism—PRSS3—urinary bladder cancer	4.37e-05	0.00086	CbGpPWpGaD
Azathioprine—Haemorrhage—Methotrexate—urinary bladder cancer	4.37e-05	0.00109	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—MYC—urinary bladder cancer	4.35e-05	0.000855	CbGpPWpGaD
Azathioprine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	4.31e-05	0.00107	CcSEcCtD
Azathioprine—XDH—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	4.3e-05	0.000845	CbGpPWpGaD
Azathioprine—Nausea—Thiotepa—urinary bladder cancer	4.28e-05	0.00107	CcSEcCtD
Azathioprine—Feeling abnormal—Etoposide—urinary bladder cancer	4.27e-05	0.00106	CcSEcCtD
Azathioprine—TPMT—Metabolism—UGT2B7—urinary bladder cancer	4.26e-05	0.000836	CbGpPWpGaD
Azathioprine—Agranulocytosis—Epirubicin—urinary bladder cancer	4.25e-05	0.00106	CcSEcCtD
Azathioprine—Pneumonia—Doxorubicin—urinary bladder cancer	4.24e-05	0.00106	CcSEcCtD
Azathioprine—Gastrointestinal pain—Etoposide—urinary bladder cancer	4.24e-05	0.00105	CcSEcCtD
Azathioprine—Infestation—Doxorubicin—urinary bladder cancer	4.21e-05	0.00105	CcSEcCtD
Azathioprine—Infestation NOS—Doxorubicin—urinary bladder cancer	4.21e-05	0.00105	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	4.18e-05	0.00104	CcSEcCtD
Azathioprine—Hypersensitivity—Cisplatin—urinary bladder cancer	4.17e-05	0.00104	CcSEcCtD
Azathioprine—Diarrhoea—Gemcitabine—urinary bladder cancer	4.15e-05	0.00103	CcSEcCtD
Azathioprine—Erythema multiforme—Methotrexate—urinary bladder cancer	4.13e-05	0.00103	CcSEcCtD
Azathioprine—GSTA2—Metabolism—GSTZ1—urinary bladder cancer	4.11e-05	0.000808	CbGpPWpGaD
Azathioprine—Haemoglobin—Epirubicin—urinary bladder cancer	4.11e-05	0.00102	CcSEcCtD
Azathioprine—Abdominal pain—Etoposide—urinary bladder cancer	4.09e-05	0.00102	CcSEcCtD
Azathioprine—Body temperature increased—Etoposide—urinary bladder cancer	4.09e-05	0.00102	CcSEcCtD
Azathioprine—Haemorrhage—Epirubicin—urinary bladder cancer	4.09e-05	0.00102	CcSEcCtD
Azathioprine—Diarrhoea—Fluorouracil—urinary bladder cancer	4.08e-05	0.00102	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—KRAS—urinary bladder cancer	4.02e-05	0.00079	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—TYMP—urinary bladder cancer	4e-05	0.000786	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—GSTZ1—urinary bladder cancer	4e-05	0.000786	CbGpPWpGaD
Azathioprine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	3.98e-05	0.000992	CcSEcCtD
Azathioprine—Immune system disorder—Methotrexate—urinary bladder cancer	3.94e-05	0.000982	CcSEcCtD
Azathioprine—Dizziness—Fluorouracil—urinary bladder cancer	3.94e-05	0.000982	CcSEcCtD
Azathioprine—Mediastinal disorder—Methotrexate—urinary bladder cancer	3.94e-05	0.00098	CcSEcCtD
Azathioprine—Agranulocytosis—Doxorubicin—urinary bladder cancer	3.93e-05	0.000979	CcSEcCtD
Azathioprine—Chills—Methotrexate—urinary bladder cancer	3.92e-05	0.000976	CcSEcCtD
Azathioprine—GSTA2—Metabolism—GSTO2—urinary bladder cancer	3.9e-05	0.000766	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—NAT1—urinary bladder cancer	3.9e-05	0.000766	CbGpPWpGaD
Azathioprine—Diarrhoea—Cisplatin—urinary bladder cancer	3.87e-05	0.000963	CcSEcCtD
Azathioprine—Erythema multiforme—Epirubicin—urinary bladder cancer	3.86e-05	0.000962	CcSEcCtD
Azathioprine—Alopecia—Methotrexate—urinary bladder cancer	3.86e-05	0.000961	CcSEcCtD
Azathioprine—Vomiting—Gemcitabine—urinary bladder cancer	3.86e-05	0.00096	CcSEcCtD
Azathioprine—TPMT—Metabolism—CYP4B1—urinary bladder cancer	3.83e-05	0.000753	CbGpPWpGaD
Azathioprine—Rash—Gemcitabine—urinary bladder cancer	3.82e-05	0.000952	CcSEcCtD
Azathioprine—Dermatitis—Gemcitabine—urinary bladder cancer	3.82e-05	0.000952	CcSEcCtD
Azathioprine—Hypersensitivity—Etoposide—urinary bladder cancer	3.82e-05	0.00095	CcSEcCtD
Azathioprine—Haemoglobin—Doxorubicin—urinary bladder cancer	3.8e-05	0.000946	CcSEcCtD
Azathioprine—Headache—Gemcitabine—urinary bladder cancer	3.8e-05	0.000946	CcSEcCtD
Azathioprine—GSTM1—Metabolism—GSTO2—urinary bladder cancer	3.79e-05	0.000746	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—NAT1—urinary bladder cancer	3.79e-05	0.000746	CbGpPWpGaD
Azathioprine—Vomiting—Fluorouracil—urinary bladder cancer	3.79e-05	0.000944	CcSEcCtD
Azathioprine—Haemorrhage—Doxorubicin—urinary bladder cancer	3.78e-05	0.000942	CcSEcCtD
Azathioprine—Rash—Fluorouracil—urinary bladder cancer	3.76e-05	0.000936	CcSEcCtD
Azathioprine—Dermatitis—Fluorouracil—urinary bladder cancer	3.76e-05	0.000936	CcSEcCtD
Azathioprine—Headache—Fluorouracil—urinary bladder cancer	3.74e-05	0.00093	CcSEcCtD
Azathioprine—Immune system disorder—Epirubicin—urinary bladder cancer	3.69e-05	0.000919	CcSEcCtD
Azathioprine—Mediastinal disorder—Epirubicin—urinary bladder cancer	3.68e-05	0.000917	CcSEcCtD
Azathioprine—Chills—Epirubicin—urinary bladder cancer	3.67e-05	0.000913	CcSEcCtD
Azathioprine—Arrhythmia—Epirubicin—urinary bladder cancer	3.65e-05	0.000909	CcSEcCtD
Azathioprine—HPRT1—Metabolism—NAT2—urinary bladder cancer	3.62e-05	0.000711	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—SLC19A1—urinary bladder cancer	3.62e-05	0.000711	CbGpPWpGaD
Azathioprine—Alopecia—Epirubicin—urinary bladder cancer	3.61e-05	0.000899	CcSEcCtD
Azathioprine—Nausea—Gemcitabine—urinary bladder cancer	3.6e-05	0.000897	CcSEcCtD
Azathioprine—Vomiting—Cisplatin—urinary bladder cancer	3.59e-05	0.000895	CcSEcCtD
Azathioprine—Erythema multiforme—Doxorubicin—urinary bladder cancer	3.57e-05	0.00089	CcSEcCtD
Azathioprine—GSTA2—Metabolism—UGT2B7—urinary bladder cancer	3.57e-05	0.000701	CbGpPWpGaD
Azathioprine—Rash—Cisplatin—urinary bladder cancer	3.56e-05	0.000888	CcSEcCtD
Azathioprine—Dermatitis—Cisplatin—urinary bladder cancer	3.56e-05	0.000887	CcSEcCtD
Azathioprine—Diarrhoea—Etoposide—urinary bladder cancer	3.54e-05	0.000883	CcSEcCtD
Azathioprine—Nausea—Fluorouracil—urinary bladder cancer	3.54e-05	0.000882	CcSEcCtD
Azathioprine—Ill-defined disorder—Methotrexate—urinary bladder cancer	3.53e-05	0.000878	CcSEcCtD
Azathioprine—TPMT—Metabolism—PRSS3—urinary bladder cancer	3.53e-05	0.000693	CbGpPWpGaD
Azathioprine—Anaemia—Methotrexate—urinary bladder cancer	3.51e-05	0.000875	CcSEcCtD
Azathioprine—GSTA1—Metabolism—TYMP—urinary bladder cancer	3.5e-05	0.000687	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—UGT2B7—urinary bladder cancer	3.47e-05	0.000682	CbGpPWpGaD
Azathioprine—Malaise—Methotrexate—urinary bladder cancer	3.43e-05	0.000854	CcSEcCtD
Azathioprine—Dizziness—Etoposide—urinary bladder cancer	3.42e-05	0.000853	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—HRAS—urinary bladder cancer	3.42e-05	0.000672	CbGpPWpGaD
Azathioprine—Immune system disorder—Doxorubicin—urinary bladder cancer	3.42e-05	0.000851	CcSEcCtD
Azathioprine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	3.41e-05	0.000849	CcSEcCtD
Azathioprine—Leukopenia—Methotrexate—urinary bladder cancer	3.4e-05	0.000847	CcSEcCtD
Azathioprine—Chills—Doxorubicin—urinary bladder cancer	3.39e-05	0.000845	CcSEcCtD
Azathioprine—Arrhythmia—Doxorubicin—urinary bladder cancer	3.38e-05	0.000841	CcSEcCtD
Azathioprine—Nausea—Cisplatin—urinary bladder cancer	3.36e-05	0.000836	CcSEcCtD
Azathioprine—Alopecia—Doxorubicin—urinary bladder cancer	3.34e-05	0.000832	CcSEcCtD
Azathioprine—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.3e-05	0.000822	CcSEcCtD
Azathioprine—Vomiting—Etoposide—urinary bladder cancer	3.29e-05	0.00082	CcSEcCtD
Azathioprine—Anaemia—Epirubicin—urinary bladder cancer	3.29e-05	0.000819	CcSEcCtD
Azathioprine—Rash—Etoposide—urinary bladder cancer	3.27e-05	0.000813	CcSEcCtD
Azathioprine—Dermatitis—Etoposide—urinary bladder cancer	3.26e-05	0.000813	CcSEcCtD
Azathioprine—Headache—Etoposide—urinary bladder cancer	3.24e-05	0.000808	CcSEcCtD
Azathioprine—Myalgia—Methotrexate—urinary bladder cancer	3.24e-05	0.000806	CcSEcCtD
Azathioprine—Arthralgia—Methotrexate—urinary bladder cancer	3.24e-05	0.000806	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.21e-05	0.0008	CcSEcCtD
Azathioprine—GSTA2—Metabolism—CYP4B1—urinary bladder cancer	3.21e-05	0.000631	CbGpPWpGaD
Azathioprine—Malaise—Epirubicin—urinary bladder cancer	3.21e-05	0.000799	CcSEcCtD
Azathioprine—Discomfort—Methotrexate—urinary bladder cancer	3.2e-05	0.000796	CcSEcCtD
Azathioprine—Leukopenia—Epirubicin—urinary bladder cancer	3.18e-05	0.000793	CcSEcCtD
Azathioprine—GSTA1—Metabolism—NAT2—urinary bladder cancer	3.16e-05	0.000622	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—RRM2—urinary bladder cancer	3.12e-05	0.000614	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CYP4B1—urinary bladder cancer	3.12e-05	0.000614	CbGpPWpGaD
Azathioprine—Infection—Methotrexate—urinary bladder cancer	3.08e-05	0.000768	CcSEcCtD
Azathioprine—Nausea—Etoposide—urinary bladder cancer	3.08e-05	0.000766	CcSEcCtD
Azathioprine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.05e-05	0.000761	CcSEcCtD
Azathioprine—Anaemia—Doxorubicin—urinary bladder cancer	3.04e-05	0.000758	CcSEcCtD
Azathioprine—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.04e-05	0.000756	CcSEcCtD
Azathioprine—GSTA2—Metabolism—SLC19A1—urinary bladder cancer	3.03e-05	0.000596	CbGpPWpGaD
Azathioprine—Myalgia—Epirubicin—urinary bladder cancer	3.03e-05	0.000754	CcSEcCtD
Azathioprine—Arthralgia—Epirubicin—urinary bladder cancer	3.03e-05	0.000754	CcSEcCtD
Azathioprine—Skin disorder—Methotrexate—urinary bladder cancer	3.01e-05	0.00075	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.01e-05	0.000749	CcSEcCtD
Azathioprine—Discomfort—Epirubicin—urinary bladder cancer	2.99e-05	0.000745	CcSEcCtD
Azathioprine—XDH—Metabolism—GSTZ1—urinary bladder cancer	2.97e-05	0.000585	CbGpPWpGaD
Azathioprine—Malaise—Doxorubicin—urinary bladder cancer	2.97e-05	0.000739	CcSEcCtD
Azathioprine—GSTA2—Metabolism—PRSS3—urinary bladder cancer	2.95e-05	0.000581	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—SLC19A1—urinary bladder cancer	2.95e-05	0.00058	CbGpPWpGaD
Azathioprine—Leukopenia—Doxorubicin—urinary bladder cancer	2.95e-05	0.000734	CcSEcCtD
Azathioprine—XDH—Selenium Micronutrient Network—TNF—urinary bladder cancer	2.9e-05	0.00057	CbGpPWpGaD
Azathioprine—Hypotension—Methotrexate—urinary bladder cancer	2.9e-05	0.000722	CcSEcCtD
Azathioprine—HPRT1—Metabolism—ENO2—urinary bladder cancer	2.89e-05	0.000569	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—HPGDS—urinary bladder cancer	2.89e-05	0.000569	CbGpPWpGaD
Azathioprine—Infection—Epirubicin—urinary bladder cancer	2.88e-05	0.000718	CcSEcCtD
Azathioprine—GSTM1—Metabolism—PRSS3—urinary bladder cancer	2.87e-05	0.000565	CbGpPWpGaD
Azathioprine—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.84e-05	0.000708	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.83e-05	0.000704	CcSEcCtD
Azathioprine—Skin disorder—Epirubicin—urinary bladder cancer	2.82e-05	0.000702	CcSEcCtD
Azathioprine—XDH—Metabolism—GSTO2—urinary bladder cancer	2.82e-05	0.000554	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—TYMP—urinary bladder cancer	2.82e-05	0.000554	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NAT1—urinary bladder cancer	2.82e-05	0.000554	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—GSTT1—urinary bladder cancer	2.81e-05	0.000551	CbGpPWpGaD
Azathioprine—Myalgia—Doxorubicin—urinary bladder cancer	2.8e-05	0.000698	CcSEcCtD
Azathioprine—Arthralgia—Doxorubicin—urinary bladder cancer	2.8e-05	0.000698	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	2.78e-05	0.000693	CcSEcCtD
Azathioprine—Discomfort—Doxorubicin—urinary bladder cancer	2.77e-05	0.00069	CcSEcCtD
Azathioprine—GSTA1—Metabolism—RRM2—urinary bladder cancer	2.73e-05	0.000537	CbGpPWpGaD
Azathioprine—Hypotension—Epirubicin—urinary bladder cancer	2.71e-05	0.000676	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.68e-05	0.000667	CcSEcCtD
Azathioprine—Infection—Doxorubicin—urinary bladder cancer	2.67e-05	0.000665	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.65e-05	0.000659	CcSEcCtD
Azathioprine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.63e-05	0.000655	CcSEcCtD
Azathioprine—Skin disorder—Doxorubicin—urinary bladder cancer	2.61e-05	0.00065	CcSEcCtD
Azathioprine—XDH—Metabolism—UGT2B7—urinary bladder cancer	2.58e-05	0.000507	CbGpPWpGaD
Azathioprine—Feeling abnormal—Methotrexate—urinary bladder cancer	2.56e-05	0.000637	CcSEcCtD
Azathioprine—TPMT—Metabolism—NAT2—urinary bladder cancer	2.55e-05	0.000501	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.54e-05	0.000632	CcSEcCtD
Azathioprine—GSTA1—Metabolism—ENO2—urinary bladder cancer	2.53e-05	0.000497	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—HPGDS—urinary bladder cancer	2.53e-05	0.000497	CbGpPWpGaD
Azathioprine—Hypotension—Doxorubicin—urinary bladder cancer	2.51e-05	0.000625	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.51e-05	0.000624	CcSEcCtD
Azathioprine—Body temperature increased—Methotrexate—urinary bladder cancer	2.45e-05	0.000611	CcSEcCtD
Azathioprine—Abdominal pain—Methotrexate—urinary bladder cancer	2.45e-05	0.000611	CcSEcCtD
Azathioprine—GSTA1—Metabolism—GSTT1—urinary bladder cancer	2.45e-05	0.000482	CbGpPWpGaD
Azathioprine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.45e-05	0.00061	CcSEcCtD
Azathioprine—Feeling abnormal—Epirubicin—urinary bladder cancer	2.39e-05	0.000596	CcSEcCtD
Azathioprine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.37e-05	0.000591	CcSEcCtD
Azathioprine—GSTA2—Metabolism—TYMP—urinary bladder cancer	2.36e-05	0.000464	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—NQO1—urinary bladder cancer	2.33e-05	0.000458	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CYP4B1—urinary bladder cancer	2.32e-05	0.000456	CbGpPWpGaD
Azathioprine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.32e-05	0.000578	CcSEcCtD
Azathioprine—GSTM1—Metabolism—TYMP—urinary bladder cancer	2.3e-05	0.000452	CbGpPWpGaD
Azathioprine—Abdominal pain—Epirubicin—urinary bladder cancer	2.3e-05	0.000572	CcSEcCtD
Azathioprine—Body temperature increased—Epirubicin—urinary bladder cancer	2.3e-05	0.000572	CcSEcCtD
Azathioprine—Hypersensitivity—Methotrexate—urinary bladder cancer	2.29e-05	0.000569	CcSEcCtD
Azathioprine—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.21e-05	0.000551	CcSEcCtD
Azathioprine—TPMT—Metabolism—RRM2—urinary bladder cancer	2.2e-05	0.000433	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.2e-05	0.000547	CcSEcCtD
Azathioprine—XDH—Metabolism—SLC19A1—urinary bladder cancer	2.19e-05	0.000431	CbGpPWpGaD
Azathioprine—Hypersensitivity—Epirubicin—urinary bladder cancer	2.14e-05	0.000533	CcSEcCtD
Azathioprine—XDH—Metabolism—PRSS3—urinary bladder cancer	2.14e-05	0.00042	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—NAT2—urinary bladder cancer	2.14e-05	0.00042	CbGpPWpGaD
Azathioprine—Body temperature increased—Doxorubicin—urinary bladder cancer	2.12e-05	0.000529	CcSEcCtD
Azathioprine—Abdominal pain—Doxorubicin—urinary bladder cancer	2.12e-05	0.000529	CcSEcCtD
Azathioprine—Diarrhoea—Methotrexate—urinary bladder cancer	2.12e-05	0.000529	CcSEcCtD
Azathioprine—GSTM1—Metabolism—NAT2—urinary bladder cancer	2.08e-05	0.000409	CbGpPWpGaD
Azathioprine—Dizziness—Methotrexate—urinary bladder cancer	2.05e-05	0.000511	CcSEcCtD
Azathioprine—TPMT—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000401	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000401	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—NQO1—urinary bladder cancer	2.04e-05	0.000401	CbGpPWpGaD
Azathioprine—Diarrhoea—Epirubicin—urinary bladder cancer	1.99e-05	0.000495	CcSEcCtD
Azathioprine—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.98e-05	0.000493	CcSEcCtD
Azathioprine—TPMT—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000389	CbGpPWpGaD
Azathioprine—Vomiting—Methotrexate—urinary bladder cancer	1.97e-05	0.000491	CcSEcCtD
Azathioprine—Rash—Methotrexate—urinary bladder cancer	1.96e-05	0.000487	CcSEcCtD
Azathioprine—Dermatitis—Methotrexate—urinary bladder cancer	1.95e-05	0.000487	CcSEcCtD
Azathioprine—HPRT1—Metabolism—GSTP1—urinary bladder cancer	1.94e-05	0.000382	CbGpPWpGaD
Azathioprine—Headache—Methotrexate—urinary bladder cancer	1.94e-05	0.000484	CcSEcCtD
Azathioprine—Dizziness—Epirubicin—urinary bladder cancer	1.92e-05	0.000478	CcSEcCtD
Azathioprine—Vomiting—Epirubicin—urinary bladder cancer	1.85e-05	0.00046	CcSEcCtD
Azathioprine—GSTA2—Metabolism—RRM2—urinary bladder cancer	1.84e-05	0.000362	CbGpPWpGaD
Azathioprine—Nausea—Methotrexate—urinary bladder cancer	1.84e-05	0.000459	CcSEcCtD
Azathioprine—Diarrhoea—Doxorubicin—urinary bladder cancer	1.84e-05	0.000458	CcSEcCtD
Azathioprine—Rash—Epirubicin—urinary bladder cancer	1.83e-05	0.000456	CcSEcCtD
Azathioprine—Dermatitis—Epirubicin—urinary bladder cancer	1.83e-05	0.000455	CcSEcCtD
Azathioprine—Headache—Epirubicin—urinary bladder cancer	1.82e-05	0.000453	CcSEcCtD
Azathioprine—HPRT1—Metabolism—TYMS—urinary bladder cancer	1.81e-05	0.000355	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000353	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—NCOR1—urinary bladder cancer	1.79e-05	0.000351	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—GSTM1—urinary bladder cancer	1.79e-05	0.000351	CbGpPWpGaD
Azathioprine—Dizziness—Doxorubicin—urinary bladder cancer	1.78e-05	0.000442	CcSEcCtD
Azathioprine—Nausea—Epirubicin—urinary bladder cancer	1.72e-05	0.000429	CcSEcCtD
Azathioprine—HPRT1—Metabolism—GPX1—urinary bladder cancer	1.71e-05	0.000336	CbGpPWpGaD
Azathioprine—Vomiting—Doxorubicin—urinary bladder cancer	1.71e-05	0.000425	CcSEcCtD
Azathioprine—GSTA2—Metabolism—ENO2—urinary bladder cancer	1.71e-05	0.000336	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—HPGDS—urinary bladder cancer	1.71e-05	0.000336	CbGpPWpGaD
Azathioprine—XDH—Metabolism—TYMP—urinary bladder cancer	1.71e-05	0.000336	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—GSTP1—urinary bladder cancer	1.7e-05	0.000334	CbGpPWpGaD
Azathioprine—Rash—Doxorubicin—urinary bladder cancer	1.69e-05	0.000422	CcSEcCtD
Azathioprine—Dermatitis—Doxorubicin—urinary bladder cancer	1.69e-05	0.000421	CcSEcCtD
Azathioprine—Headache—Doxorubicin—urinary bladder cancer	1.68e-05	0.000419	CcSEcCtD
Azathioprine—HPRT1—Metabolism—ERCC2—urinary bladder cancer	1.68e-05	0.00033	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—HPGDS—urinary bladder cancer	1.66e-05	0.000327	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—ENO2—urinary bladder cancer	1.66e-05	0.000327	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—GSTT1—urinary bladder cancer	1.66e-05	0.000326	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.000323	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—GSTT1—urinary bladder cancer	1.61e-05	0.000317	CbGpPWpGaD
Azathioprine—Nausea—Doxorubicin—urinary bladder cancer	1.6e-05	0.000397	CcSEcCtD
Azathioprine—GSTA1—Metabolism—TYMS—urinary bladder cancer	1.58e-05	0.000311	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.00031	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—GSTM1—urinary bladder cancer	1.56e-05	0.000307	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—NCOR1—urinary bladder cancer	1.56e-05	0.000307	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NAT2—urinary bladder cancer	1.54e-05	0.000304	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—GPX1—urinary bladder cancer	1.5e-05	0.000294	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—ERCC2—urinary bladder cancer	1.47e-05	0.000289	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—MTHFR—urinary bladder cancer	1.38e-05	0.000271	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—NQO1—urinary bladder cancer	1.38e-05	0.000271	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.000269	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—NQO1—urinary bladder cancer	1.34e-05	0.000263	CbGpPWpGaD
Azathioprine—XDH—Metabolism—RRM2—urinary bladder cancer	1.33e-05	0.000262	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PPARG—urinary bladder cancer	1.28e-05	0.000252	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.00025	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.000247	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.000247	CbGpPWpGaD
Azathioprine—XDH—Metabolism—ENO2—urinary bladder cancer	1.23e-05	0.000243	CbGpPWpGaD
Azathioprine—XDH—Metabolism—HPGDS—urinary bladder cancer	1.23e-05	0.000243	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	0.000242	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000237	CbGpPWpGaD
Azathioprine—XDH—Metabolism—GSTT1—urinary bladder cancer	1.2e-05	0.000235	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000233	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—GSTP1—urinary bladder cancer	1.15e-05	0.000226	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PPARG—urinary bladder cancer	1.12e-05	0.00022	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.00022	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000219	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000211	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—TYMS—urinary bladder cancer	1.07e-05	0.00021	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	0.000207	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	0.000207	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—TYMS—urinary bladder cancer	1.04e-05	0.000204	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	0.000202	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—GPX1—urinary bladder cancer	1.01e-05	0.000199	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000198	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NQO1—urinary bladder cancer	9.95e-06	0.000196	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—ERCC2—urinary bladder cancer	9.92e-06	0.000195	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—GPX1—urinary bladder cancer	9.83e-06	0.000193	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—ERCC2—urinary bladder cancer	9.65e-06	0.00019	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—MTHFR—urinary bladder cancer	9.32e-06	0.000183	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—MTHFR—urinary bladder cancer	9.07e-06	0.000178	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PPARG—urinary bladder cancer	9.02e-06	0.000177	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTGS2—urinary bladder cancer	8.81e-06	0.000173	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTEN—urinary bladder cancer	8.79e-06	0.000173	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—CREBBP—urinary bladder cancer	8.67e-06	0.00017	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—EP300—urinary bladder cancer	8.38e-06	0.000165	CbGpPWpGaD
Azathioprine—XDH—Metabolism—GSTP1—urinary bladder cancer	8.3e-06	0.000163	CbGpPWpGaD
Azathioprine—XDH—Metabolism—TYMS—urinary bladder cancer	7.72e-06	0.000152	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTEN—urinary bladder cancer	7.68e-06	0.000151	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NCOR1—urinary bladder cancer	7.63e-06	0.00015	CbGpPWpGaD
Azathioprine—XDH—Metabolism—GSTM1—urinary bladder cancer	7.63e-06	0.00015	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PPARG—urinary bladder cancer	7.56e-06	0.000149	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PPARG—urinary bladder cancer	7.36e-06	0.000145	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—EP300—urinary bladder cancer	7.32e-06	0.000144	CbGpPWpGaD
Azathioprine—XDH—Metabolism—GPX1—urinary bladder cancer	7.3e-06	0.000144	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CREBBP—urinary bladder cancer	7.26e-06	0.000143	CbGpPWpGaD
Azathioprine—XDH—Metabolism—ERCC2—urinary bladder cancer	7.17e-06	0.000141	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTGS2—urinary bladder cancer	7.1e-06	0.00014	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CREBBP—urinary bladder cancer	7.07e-06	0.000139	CbGpPWpGaD
Azathioprine—XDH—Metabolism—MTHFR—urinary bladder cancer	6.74e-06	0.000133	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTEN—urinary bladder cancer	6.19e-06	0.000122	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTGS2—urinary bladder cancer	5.95e-06	0.000117	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—EP300—urinary bladder cancer	5.9e-06	0.000116	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTGS2—urinary bladder cancer	5.79e-06	0.000114	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PPARG—urinary bladder cancer	5.47e-06	0.000107	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CREBBP—urinary bladder cancer	5.25e-06	0.000103	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTEN—urinary bladder cancer	5.19e-06	0.000102	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTEN—urinary bladder cancer	5.05e-06	9.92e-05	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—EP300—urinary bladder cancer	4.95e-06	9.72e-05	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—EP300—urinary bladder cancer	4.81e-06	9.46e-05	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTGS2—urinary bladder cancer	4.3e-06	8.45e-05	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTEN—urinary bladder cancer	3.75e-06	7.37e-05	CbGpPWpGaD
Azathioprine—XDH—Metabolism—EP300—urinary bladder cancer	3.58e-06	7.03e-05	CbGpPWpGaD
